-- Earnings Flash (ARAV) ARAVIVE Posts Q2 Revenue $1.6M
7:01AM ET 8/11/2022 MT Newswires...
Aravive (ARAV) has an average rating of buy and price targets ranging from $6 to $26, according to analysts polled by Capital IQ. (MT Newswires covers...
Aravive (ARAV) said Friday that it has appointed Rudy Howard as chief financial officer, effective immediately. Vinay Shah has stepped down as CFO for...
Aravive (ARAV) has an average rating of buy and price targets ranging from $6 to $26, according to analysts polled by Capital IQ. (MT Newswires covers...
Address | River Oaks Tower Houston, Texas 77098 |
Phone | +1.936.355.1910 |
Number of Employees | 14 |
President, Chief Executive Officer & Director | Gail Frances McIntyre |
Chief Operating Officer | Leonard Scott Dove |
Chief Financial & Accounting Officer | Rudy C. Howard |
Chief Medical Officer | Robert B. Geller |
Price Open | $0.95 |
Previous Close | $0.93 |
52 Week Range | $0.80 - 4.40 |
Market Capitalization | $27.3 M |
Shares Outstanding | 30.5 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 10/27/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$2.42 |
Beta vs. S&P 500 | N/A |
Revenue | $1.4 M |
Net Profit Margin | -910.48% |
Return on Equity | -134.06% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |